Asia Vital Components Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St

March 16, 2025

Asia Vital Components (TWSE:3017) Full Year 2024 Results

Key Financial Results

Revenue: NT$71.8b (up 21% from FY 2023).
Net income: NT$8.17b (up 54% from FY 2023).
Profit margin: 11% (up from 9.0% in FY 2023). The increase in margin was driven by higher revenue.
EPS: NT$21.21 (up from NT$14.11 in FY 2023).

revenue-and-expenses-breakdown — TWSE:3017 Revenue and Expenses Breakdown March 16th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Asia Vital Components EPS Misses Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 1.6%.

The primary driver behind last 12 months revenue was the Overseas Business Department segment contributing a total revenue of NT$81.4b (113% of total revenue). Notably, cost of sales worth NT$54.9b amounted to 76% of total revenue thereby underscoring the impact on earnings. The largest operating expense was Research & Development (R&D) costs, amounting to NT$4.10b (47% of total expenses). Explore how 3017's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Tech industry in Taiwan.

Performance of the Taiwanese Tech industry.

The company's shares are up 3.0% from a week ago.

Risk Analysis

It is worth noting though that we have found 1 warning sign for Asia Vital Components that you need to take into consideration.

Mobile Infrastructure for Defense and Disaster

The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.

Get the investor briefing before the next round of contracts

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.